Lan Mu

Statistics

Publications

Citations

310

H-Index

Active since

2017

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Second Xiangya Hospital of Central South University

Icahn School of Medicine at Mount Sinai

Jiangsu Hengrui Medicine (China)

Central South University

Lan Mu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in radiation oncology, immunology, and tumor immunity.

ORCID

Top concepts

MedicineOncologyPathologyImmunologyImmunotherapyCancer TherapyTumor ImmunityMolecular OncologyRadiation Oncology

Publications per year

2017–2022

Publications

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Bo Zhang, Ling Qi, Xi Wang et al. · Cancer Communications · 2020 · 135 citations · Full text

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

Lan Mu, Ke Ding, Ranran Tu et al. · Journal of Translational Medicine · 2021 · 42 citations · Full text

<scp>SHR‐1316</scp>, an <scp>anti‐PD‐L1</scp> antibody, plus chemotherapy as the first‐line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase <scp>2</scp> study

Lan Mu, Yan Song, Kuaile Zhao et al. · Thoracic Cancer · 2021 · 32 citations · Full text

Human papillomavirus infection increases the risk of breast carcinoma: a large-scale systemic review and meta-analysis of case-control studies

Chutong Ren, Kai Zeng, Chujun Wu et al. · Gland Surgery · 2019 · 27 citations · Full text

Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast

Meng Xiao, Zhengjun Yang, Xiaochuan Tang et al. · Oncology Letters · 2017 · 19 citations · Full text

1–5 of 9